Skip to the page

Data / Drug companies / Oxcarbazepine

Oxcarbazepine: 46 companies and 129 products in the FDA NDC directory

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Oxcarbazepine is listed in the FDA National Drug Code Directory by 46 companies, with 129 products in commercial distribution. 122 of the products (94.6%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, film coated; suspension; tablet, and the newest product started marketing on October 16, 2026.

The request: Get every company that lists oxcarbazepine in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Companies listing it
46
Products
129
Generic (ANDA) products
122 (94.6%)
Application numbers
27
Routes
Oral
Brand names
Trileptal, Oxtellar XR
openFDA record search
api.fda.gov

Companies that list oxcarbazepine

Ranked by number of products. Finished drugs in commercial distribution.

CompanyProductsMain dosage formsMain marketing categoryNewest product started
Remedyrepack Inc.13tablet, film coatedGeneric drugs (ANDA)May 20, 2026
Advagen Pharma Ltd7tablet; tablet, film coatedGeneric drugs (ANDA)May 20, 2025
Breckenridge Pharmaceutical, Inc.6tablet, film coatedGeneric drugs (ANDA)January 11, 2008
Major Pharmaceuticals6tablet, film coatedGeneric drugs (ANDA)April 3, 2026
Coupler LLC5tablet, film coatedGeneric drugs (ANDA)May 6, 2026
Camber Pharmaceuticals, Inc.4tablet, film coated; suspensionGeneric drugs (ANDA)October 20, 2023
Cardinal Health 107, LLC4tablet, film coatedGeneric drugs (ANDA)January 24, 2023
Novartis Pharmaceuticals Corporation4tablet, film coated; suspensionNew drug applications (NDA)May 30, 2001
Ajanta Pharma USA Inc.3tablet, extended releaseGeneric drugs (ANDA)February 22, 2024
American Health Packaging3tablet, film coatedGeneric drugs (ANDA)February 2, 2023
Ani Pharmaceuticals, Inc.3tablet, film coatedGeneric drugs (ANDA)July 15, 2025
Apotex Corp.3tablet, extended releaseGeneric drugs (ANDA)September 3, 2024
Aurobindo Pharma Limited3tablet, film coated, extended releaseGeneric drugs (ANDA)October 16, 2026
AvPAK3tablet, film coatedGeneric drugs (ANDA)June 7, 2023
Bryant Ranch Prepack3tablet, film coatedGeneric drugs (ANDA)January 11, 2008
Bryant Ranch Prepack3suspension; tablet, film coatedGeneric drugs (ANDA)May 1, 2025
Glenmark Pharmaceuticals Inc., USA3tablet, film coatedGeneric drugs (ANDA)October 9, 2007
Golden State Medical Supply, Inc.3tablet, film coatedGeneric drugs (ANDA)January 11, 2008
Ingenus Pharmaceuticals, LLC3tablet, extended releaseGeneric drugs (ANDA)June 1, 2025
NCS HealthCare of Ky, LLC DBA Vangard Labs3tablet, film coatedGeneric drugs (ANDA)July 15, 2025
NorthStar RxLLC3tablet, film coated; suspensionGeneric drugs (ANDA)September 1, 2024
Sun Pharmaceutical Industries, Inc.3tablet, film coatedGeneric drugs (ANDA)October 9, 2007
Supernus Pharmaceuticals, Inc.3tabletNew drug applications (NDA)January 17, 2013
Umedica Laboratories USA Inc.3tablet, film coatedGeneric drugs (ANDA)January 1, 2026
XLCare Pharmaceuticals, Inc.3tablet, film coatedGeneric drugs (ANDA)July 18, 2024
Zameer Pharmaceuticals LLC3tablet, film coatedGeneric drugs (ANDA)July 6, 2026
Zydus Lifesciences Limited3tabletGeneric drugs (ANDA)July 10, 2025
Zydus Pharmaceuticals USA Inc.3tabletGeneric drugs (ANDA)July 10, 2025
Bryant Ranch Prepack2tablet, film coatedGeneric drugs (ANDA)January 11, 2022
Direct_Rx2tablet, film coatedGeneric drugs (ANDA)September 9, 2024
Amneal Pharmaceuticals LLC1suspensionGeneric drugs (ANDA)June 4, 2012
Ascend Laboratories, LLC1suspensionGeneric drugs (ANDA)January 1, 2020
Asclemed USA Inc.1tablet, film coatedGeneric drugs (ANDA)January 11, 2022
Biocon Pharma Inc.1suspensionGeneric drugs (ANDA)May 31, 2024
Bionpharma Inc.1suspensionGeneric drugs (ANDA)February 14, 2023
Chartwell Governmental & Specialty RX, LLC.1suspensionGeneric drugs (ANDA)September 21, 2021
Chartwell RX, LLC1suspensionGeneric drugs (ANDA)September 21, 2021
Epic Pharma, LLC1suspensionGeneric drugs (ANDA)January 30, 2023
Kanchan Healthcare Inc1suspensionGeneric drugs (ANDA)May 1, 2025
Macleods Pharmaceuticals Limited1for suspensionGeneric drugs (ANDA)July 11, 2025
Marlex Pharmaceuticals, Inc.1suspensionGeneric drugs (ANDA)May 1, 2025
Novadoz Pharmaceuticals LLC1suspensionGeneric drugs (ANDA)May 29, 2026
Precision Dose, Inc.1suspensionGeneric drugs (ANDA)September 13, 2017
Preferred Pharmaceuticals Inc.1tablet, film coatedGeneric drugs (ANDA)February 15, 2021
Proficient Rx LP1tablet, film coatedGeneric drugs (ANDA)October 9, 2007
Proficient Rx LP1tablet, film coatedGeneric drugs (ANDA)January 11, 2022

Dosage forms

Dosage formProductsShare
Tablet, film coated8767.4%
Suspension1713.2%
Tablet129.3%
Tablet, extended release97%
Tablet, film coated, extended release32.3%
For suspension10.8%

Marketing categories

Marketing categoryProductsShare
Generic drugs (ANDA)12294.6%
New drug applications (NDA)75.4%

Pharmacologic classes

ClassProducts
Anti-epileptic Agent129

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.